1.12 - Pharmacology of GORD (core drugs) Flashcards
What classes of drugs are involved in GORD? (4)
- NSAIDs (increase GORD)
- proton pump inhibitors (PPIs)
- histamine (H2) receptor antagonists
- paracetamol (AKA acetaminophen)
What are some examples of NSAIDs? (3)
And what NSAID can be used for peptic ulcer?
- ibuprofen
- naproxen
- diclofenac
Celecoxib - COX-2 specific
What is the primary mechanism of action of NSAIDs?
- inhibit the enzyme cyclo-oxygenase (COX) which is the rate-limiting step for the production of all prostanoids (prostaglandins and thromboxanes) from arachidonic acid
- prostanoids act through a large number of prostanoid receptors to produce a highly complex array of actions
- COX-2 inhibition leads to anti-inflammatory, analgesic and antipyretic effects
- unwanted side effects due to COX-1 inhibition reducing PGs (PGs increase HCO3-, mucus production, blood flow, inhibit acid production)
What is the drug target for NSAIDs?
Cyclo-oxygenase (COX) enzyme
What are the main side effects of NSAIDs? (8)
- gastric irritation, ulceration, bleeding
- gastric perforation (extreme)
- reduced creatinine clearance and possible nephritis
- chronic renal failure in prolonged analgesic abuse over years
- bronchoconstriction in susceptible individuals (contraindication in asthma)
- skin rashes & allergies, dizziness, tinnitus
- adverse cardiovascular effects (hypertension, stroke, MI) may occur with prolonged use/pre-existing CV risk
- aspirin linked with rare but serious post-viral encephalitis (Reye’s syndrome) in children
What are the main uses of NSAIDs? (4)
- analgesics for relief of mild to moderate pain (e.g. MSK pain - osteoarthritis, headache, dysmenorrhoea)
- antipyretics to reduce fever
- anti-inflammatory drugs for control of chronic inflammatory diseases e.g. RA, OA
- aspirin only: anti-aggregatory agent to inhibit platelet aggregation in stroke/MI risk patients
What are some examples of PPIs? (2)
- omeprazole
- lansoprazole
What is the primary mechanism of action of PPIs?
- irreversible inhibitors of H+/K+ ATPase in gastric parietal cells
- they are weak bases and accumulate in the acid environment of the canaliculi of the parietal cells
- this concentrates their actions there and prolongs their duration of action
- omeprazole plasma half-life is approx. 1hr but single daily dose affects acid secretion for 2-3 days
- PPIs inhibit basal and stimulated gastric acid secretion by >90%
What is the drug target of PPIs?
H+/K+ ATPase (proton pump)
What are the main side effects of PPIs?
- uncommon:
- headache
- diarrhoea
- bloating
- abdominal pain & rashes
- use of PPIs may mask gastric cancer symptoms
- omeprazole is an inhibitor of cytochrome P2C19 and has been reported to reduce the activity of e.g. clopidogrel, when platelet function is monitored
- increased fracture risk
What is some extra information about PPIs? (2)
- PPIs are pro-drugs which at low pH are converted into 2 reactive species which react with sulphydryl groups in the H+/K+ ATPase responsible for transporting H+ ions out of the parietal cells
- generally given orally but degrade rapidly at low pH so given as capsules of enteric-coated granules
What is an example of a histamine (H2) receptor antagonist?
Ranitidine
What is the primary mechanism of action of H2 antagonists?
- competitive antagonists of H2 histamine receptors (structural analogues of histamine)
- inhibit stimulatory action of histamine released from enterochromaffin-like (ECL) cells on gastric parietal cells
- inhibit gastric acid secretion by 60%
What is the drug target of H2 antagonists?
Histamine H2 receptor
What are the main side effects of H2 antagonists?
- side effect incidence is low
- diarrhoea, dizziness, muscle pains and transient rashes have been reported
- cimetidine (not other H2 antagonists) inhibits cytochrome P450 and may retard metabolism and potentiate effects of a range of drugs including oral anticoagulants and TCAs